Innovation Pharmaceuticals Inc IPIX
$0.00
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
IPIX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Innovation Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Innovation Pharmaceuticals Inc. Stock Analysis IPIX
United States Health Care Nano Cap Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. The company is headquartered in Wakefield, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2007-04-02. The firm is engaged in the business of developing or licensing small molecule therapies. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company’s efforts are primarily focused on business development for the advancement of Brilacidin. The company is primarily focused on advancement of its drug candidate Brilacidin for decreasing the incidence of severe oral mucositis as a complication of chemoradiation in oral mucositis. The firm also owns an interest in BT BeaMedical Technologies Ltd. (BTL), a private company developing an image guided surgical laser platform. The firm is monitoring BTL’s progress in advancing its laser-based thermal ablation technology platform targeting epilepsy and oncology procedures.
Innovation Pharmaceuticals Inc (IPIX) Chart
Financial Metrics & Statements of Innovation Pharmaceuticals Inc (IPIX)
FAQ's for Innovation Pharmaceuticals Inc (IPIX)
- As of August 2026, Innovation Pharmaceuticals Inc IPIX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Innovation Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Innovation Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Innovation Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Innovation Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Innovation Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Innovation Pharmaceuticals Inc (IPIX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
